Agios Pharmaceuticals
AGIO
AGIO
196 hedge funds and large institutions have $2.66B invested in Agios Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 79 increasing their positions, 55 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
30% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 40
38% less capital invested
Capital invested by funds: $4.29B → $2.66B (-$1.63B)
Holders
196
Holding in Top 10
3
Calls
$42.5M
Puts
$17.2M
Top Buyers
| 1 | +$41.2M | |
| 2 | +$31.4M | |
| 3 | +$30.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.7M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$26.3M | |
| 3 | -$22M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$18.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$14.5M |